What CORCEPT THERAPEUTICS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 41 | 108 |
| Total trades | 80 | 264 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 261,715 | 3,174,520 |
| Disposed | 373,940 | 3,677,147 |
| Net activity | −112,225 | −502,627 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Swisher Daniel N Jr | Director | Nov 10 | Open-market sale · S | −1,500 | $74.07 | −$111K | 0 |
| Swisher Daniel N Jr | Director | Nov 10 | Exercise / conversion · M | +400 | $10.50 | +$4.2K | 1,500 |
| Swisher Daniel N Jr | Director | Nov 10 | Exercise / conversion · M | +1,100 | $14.08 | +$15.5K | 1,100 |
| Maduck Sean | Insider | Nov 03 | Open-market sale · S | −4,542 | $82.68 | −$376K | 9,938 |
| Maduck Sean | Insider | Nov 03 | Open-market sale · S | −8,617 | $82.02 | −$707K | 14,480 |
| Maduck Sean | Insider | Nov 03 | Exercise / conversion · M | +13,159 | $8.27 | +$109K | 23,097 |
| Maduck Sean | Insider | Nov 02 | Open-market sale · S | −11,841 | $81.42 | −$964K | 9,938 |
| Maduck Sean | Insider | Nov 02 | Exercise / conversion · M | +11,841 | $8.27 | +$97.9K | 21,779 |
| Vieira Roberto Wandenkolk | President, Oncology | Nov 02 | Open-market sale · S | −1,676 | $81.52 | −$137K | 3,946 |
| Vieira Roberto Wandenkolk | President, Oncology | Nov 02 | Open-market sale · S | −6,657 | $80.73 | −$537K | 5,622 |
| Vieira Roberto Wandenkolk | President, Oncology | Nov 02 | Exercise / conversion · M | +8,333 | $21.63 | +$180K | 12,279 |
| Wilson James N | Director | Oct 15 | Open-market sale · S | −300 | $116.30 | −$34.9K | 1,054,543 |
| Wilson James N | Director | Oct 15 | Open-market sale · S | −3,046 | $115.39 | −$351K | 1,054,843 |
| Wilson James N | Director | Oct 15 | Open-market sale · S | −6,654 | $114.48 | −$762K | 1,057,889 |
| Vieira Roberto Wandenkolk | President, Oncology | Oct 02 | Open-market sale · S | −5,147 | $116.59 | −$600K | 3,946 |
| Vieira Roberto Wandenkolk | President, Oncology | Oct 02 | Open-market sale · S | −2,086 | $115.73 | −$241K | 9,093 |
| Vieira Roberto Wandenkolk | President, Oncology | Oct 02 | Open-market sale · S | −1,100 | $114.52 | −$126K | 11,179 |
| Vieira Roberto Wandenkolk | President, Oncology | Oct 02 | Exercise / conversion · M | +8,333 | $21.63 | +$180K | 12,279 |
| Lyon Joseph Douglas | See Remarks | Oct 02 | Open-market sale · S | −4,744 | $116.54 | −$553K | 5,683 |
| Lyon Joseph Douglas | See Remarks | Oct 02 | Open-market sale · S | −4,446 | $115.70 | −$514K | 10,427 |
Loading...